TRON Translational Oncology gGmbH at the University of Medicine University of Mainz a biopharmaceutical research institute that develops new drugs and diagnostics for the treatment of cancer and other diseases with significant unmet medical needs. The focus of TRON is the development of new platforms for personalized therapeutic approaches and biomarkers, and thus basic research oriented in the transfer of research into the development of new drugs. In cooperation with academic institutions, biotech companies and the pharmaceutical industries in research on TRON modern technologies. In addition, TRON provides its unique expertise and infrastructure of developing innovative medicines to improve patient care available.